TC Biopharm Holdings PLC
13F holders, Q3 2024 (September 30)7holders
$5.25avg. 13F price*
At the end of Q3 2024, 7 institutions reported holding TC Biopharm Holdings PLC in their 13F filings. The largest holders were FNY Investment Advisers, LLC ($43K), Signaturefd, LLC ($3K) and Harbour Investments, Inc. ($1K).
- Company
- TC Biopharm Holdings PLC
- CUSIP
- 87807D509
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $48K |
| Exits | 0 | $0 |
Ownership 7 holders
| FNY Investment Advisers, LLC | 0.02% | New | 8,200 | $43K |
| Signaturefd, LLC | 0.00% | New | 492 | $3K |
| Harbour Investments, Inc. | 0.00% | New | 236 | $1K |
| New England Capital Financial Advisors LLC | 0.00% | New | 201 | $1K |
| Morgan Stanley | 0.00% | New | 90 | $473 |
| Sanctuary Wealth Management, L.L.C. | 0.00% | New | 12 | $63 |
| Wells Fargo & Company | 0.00% | New | 5 | $26 |
"% of holder's portfolio" is TC BIOPHARM HOLDINGS PLC's weight in each manager's 13F, not the share of TC Biopharm Holdings PLC the manager owns.